Numerous studies have proven SLT to be both effi cacious and safe 3, . In total, SLT has been shown to reduce IOP in 75-85 percent of all eyes treated, a reduction that lasts anywhere between 12 months to fi ve years 4, 5, 6 , depending on the patient. Due to the non-thermal laser characteristic of SLT, it does not cause any collateral damage or burn to surrounding tissues and trabecular meshwork structure.
This unique clinical effect allows SLT to be potentially repeatable -i.e., treatment can be done on previously treated areas of the meshwork.
Clinical Evidence
One of the studies performed on the subject by Lai, et al 
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